![Pamela Stephenson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela Stephenson
Corporate Officer/Principal at
DISC MEDICINE, INC.
Net worth: 1 M $ as of 29/06/2026
Profile
Pamela Stephenson is Chief Commercial Officer at Disc Medicine, Inc. since 2024.
Formerly, Ms. Stephenson was Chief Commercial Officer at Albireo Pharma, Inc. from 2019 to 2023, Independent Director at Harmony Biosciences Management, Inc. from 2019 to 2023, and Vice President-Global Market Access & Value at Vertex Pharmaceuticals, Inc. from 2008 to 2019.
Education includes undergraduate studies at Brown University and graduate studies at Boston University School of Public Health.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
DISC MEDICINE, INC. 0.05% | 21/04/2026 | 18,665 ( 0.05% ) | 1 M $ | 29/06/2026 |
Pamela Stephenson active positions
| Companies | Position | Start |
|---|---|---|
| DISC MEDICINE, INC. | Corporate Officer/Principal | 25/02/2024 |
Former positions of Pamela Stephenson
| Companies | Position | End |
|---|---|---|
| ZYNERBA PHARMACEUTICALS, INC. | Director/Board Member | 09/10/2023 |
| ALBIREO PHARMA, INC. | Corporate Officer/Principal | 31/03/2023 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 28/02/2019 |
Training of Pamela Stephenson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Zynerba Pharmaceuticals, Inc.
 Zynerba Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Delivers dermal solutions for the treatment of neuroscience disorders | Health Technology |
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Public Health
 Boston University School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
Disc Medicine, Inc.
 Disc Medicine, Inc. BiotechnologyHealth Technology Develops therapies addressing red blood cell production in hematologic diseases | Health Technology |
- Stock Market
- Insiders
- Pamela Stephenson
